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Abstract
Background
Despite global health efforts to reduce maternal mortality, rates continue to be unacceptably
high in large parts of the world. Feasible, acceptable, and accurate postmortem sampling
methods could provide the necessary evidence to improve the understanding of the real
causes of maternal mortality, guiding the design of interventions to reduce this burden.
Methods and findings
The validity of a minimally invasive autopsy (MIA) method in determining the cause of death
was assessed in an observational study in 57 maternal deaths by comparing the results of
the MIA with those of the gold standard (complete diagnostic autopsy [CDA], which includes
any available clinical information). Concordance between the MIA and the gold standard
diagnostic categories was assessed by the kappa statistic, and the sensitivity, specificity,
positive and negative predictive values and their 95% confidence intervals (95% CI) to iden-
tify the categories of diagnoses were estimated. The main limitation of the study is that both
the MIA and the CDA include some degree of subjective interpretation in the attribution of
cause of death.
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A cause of death was identified in the CDA in 98% (56/57) of cases, with indirect obstetric
conditions accounting for 32 (56%) deaths and direct obstetric complications for 24 (42%)
deaths. Nonobstetric infectious diseases (22/32, 69%) and obstetric hemorrhage (13/24,
54%) were the most common causes of death among indirect and direct obstetric condi-
tions, respectively. Thirty-six (63%) women were HIV positive, and HIV-related conditions
accounted for 16 (28%) of all deaths. Cerebral malaria caused 4 (7%) deaths. The MIA iden-
tified a cause of death in 86% of women. The overall concordance of the MIA with the CDA
was moderate (kappa = 0.48, 95% CI: 0.31–0.66). Both methods agreed in 68% of the diag-
nostic categories and the agreement was higher for indirect (91%) than for direct obstetric
causes (38%). All HIV infections and cerebral malaria cases were identified in the MIA. The
main limitation of the technique is its relatively low performance for identifying obstetric
causes of death in the absence of clinical information.
Conclusions
The MIA procedure could be a valuable tool to determine the causes of maternal death,
especially for indirect obstetric conditions, most of which are infectious diseases.
The information provided by the MIA could help to prioritize interventions to reduce
maternal mortality and to monitor progress towards achieving global health targets.
Author summary
Why was this study done?
• Since 1990, the maternal mortality ratio (MMR) has dropped by 43%, but despite this
progress, hundreds of women still die every day in large parts of the world due to preg-
nancy or childbirth complications.
• A reliable knowledge of the causes of maternal death is a necessary condition to reduce
this burden through adequate health planning.
• Current methods, such as verbal autopsies or the review of clinical data, have shown a
high degree of misclassification in this specific group of deaths.
• We aimed to validate a minimally invasive autopsy (MIA) approach as a possible com-
plement to verbal autopsies by comparing its performance against the complete diag-
nostic autopsy, the gold standard for cause of death investigation.
What did the researchers do and find?
• We performed paired MIA and CDA in 57 maternal deaths that occurred at the Maputo
Central Hospital, Mozambique, and assessed the concordance between both methods.
• Indirect obstetric diseases caused 56% of all deaths and direct obstetric complications
accounted for 42% of deaths.
• Infectious diseases and obstetric hemorrhage were the most common causes of death
among indirect and direct obstetric conditions, respectively.
Validity of MIA in maternal deaths
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• The overall concordance of the MIA with the CDA was moderate and both methods
agreed in 68% of the diagnostic categories.
• The etiological microorganisms in infectious diseases causes of death were identified in
67% of the MIAs.
What do these findings mean?
• The MIA procedure could be a valuable tool to determine the causes of maternal death,
especially in indirect obstetric conditions, most of which are infectious diseases.
• This information may be helpful for decision-making on health planning and prioritiza-
tion of interventions to reduce maternal mortality and for monitoring progress towards
achieving global health targets.
Introduction
As the Millennium Development Goals came to a close in 2015, the maternal mortality ratio
(MMR) had dropped by 43% since 1990 [1]. Although this progress is certainly encouraging, it
is lower than the 75% target initially planned, and hundreds of women still die every day due
to complications of pregnancy or childbirth. In 2015, the number of estimated maternal deaths
occurring worldwide was 303,000, most of which were preventable and disproportionately
took place in low- and middle-income countries. The MMR in low-income countries in 2015
was 239 per 100,000 live births versus 12 per 100,000 live births in high-income countries,
according to WHO [2]. In Mozambique, in 2015, the MMR was 489 per 100,000 live births,
with an annual rate of reduction of 4.4% from 2005–2015 [3]. The aim of Sustainable Develop-
ment Goal 3.1 is to reduce the global MMR to less than 70 per 100,000 live births by 2030 [4].
The accomplishment of this objective requires robust data sources to develop accurate esti-
mates and, importantly, a thorough understanding of the causes of these deaths. Monitoring
progress towards the 5th Millennium Development Goal, focusing on maternal health,
revealed the lack of high-quality data in most countries, especially those with the highest MMR
[1].
Recently, a minimally invasive autopsy (MIA) protocol has been adapted for cause of death
determination in middle- and low-income settings [5]. This postmortem procedure, which
consists of the sampling of key organs and fluids for histological and microbiological analysis,
could add value to the currently used methods that rely on verbal autopsies and clinical rec-
ords, which have been shown to have a high level of imprecision, especially for maternal and
perinatal deaths [6,7].
The complete diagnostic autopsy (CDA) is the gold standard for cause of death determina-
tion but it is not free of limitations. The CDA is an invasive procedure, often not accepted by
the relatives, and requires trained pathologists to perform it. The MIA, as opposed to the
CDA, has been shown to be simple and more acceptable [8] and can be performed by less qual-
ified personnel. The MIA has been recently validated in a series of in-hospital stillbirth, neo-
nate, pediatric, and adult deaths in Mozambique [5]. These validation studies have shown that
the MIA may reliably identify the cause of death with high concordance when compared with
the gold standard CDA diagnosis, particularly for infectious diseases.
Validity of MIA in maternal deaths
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In this study, we analyzed the validity of the MIA to determine the cause of death in a series
of in-hospital maternal deaths from Mozambique.
Methods
Study setting and design
This observational study received the approval of the Clinical Research Ethics Committee of
the Hospital Clinic of Barcelona (Spain; approved, File 2013/8677) and the National Bioethics
Committee of Mozambique (Mozambique; approved, Ref. 342/CNBS/13).
The study was conducted at the Departments of Gynecology and Obstetrics and Pathology
of the Maputo Central Hospital, a 1,500-bed government-funded institution that serves as the
referral center for other hospitals in southern Mozambique. Recruitment of maternal deaths
was conducted from November 2013 to March 2015 as part of a comprehensive validation
study of the validity of the MIA in different age groups [9].
We included in the study all deceased women fulfilling the following inclusion criteria: (1)
death during pregnancy or within 42 days of termination of pregnancy, irrespective of its
cause (maternal deaths, as defined by WHO) [10,11]; (2) a CDA requested by the clinician as
part of the medical evaluation of the patient; and (3) oral informed consent to perform the
autopsy given by the relatives. Accidental or incidental deaths were excluded.
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
statement and the prospective analysis plan are included as supplementary information (S1
STROBE Checklist and S1 Text, respectively).
The overall study plan, indicating how postmortem procedures were performed, the labora-
tory investigations involved, and site and timing of each procedure, has been reported else-
where [5].
Autopsy procedures
Detailed MIA pathological and microbiological methods have been reported elsewhere
[12,13]. The procedure, tailored for maternal deaths, included an initial disinfection of the sur-
face of the body followed by the collection of blood and cerebrospinal fluid (CSF), aiming to
collect about 20 mL. The procedure also included the puncture of solid organs (liver, lungs,
and central nervous system [CNS]) for microbiological and pathological analysis using biopsy
needles (14G–16G). In addition, the heart, spleen, and kidneys were targeted for pathology
examination. In this particular group, biopsy samples of the uterus were attempted with a 14G
biopsy needle, which were analyzed histologically and microbiologically. In addition, a sample
of amniotic fluid, if available, was obtained.
Immediately after the MIA, the CDA procedure was conducted by a second pathologist not
involved in the MIA and following a standardized protocol for maternal autopsies [5]. Histo-
logical and microbiological analyses were conducted in samples from the same viscera col-
lected in the MIA and from any grossly identified lesions. The microbiological results of the
blood and CSF were also included in the CDA evaluation.
Histological and microbiological analyses
A team of 2 pathologists (J.O., P.Ca.) and 2 microbiologists (M.J.M., J.H.) reviewed and
analyzed the samples from the MIA blindly to any clinical data except the information on
the maternal status at death (pregnant, puerperal, previous abortion) that allowed classify-
ing the case as a maternal death. All samples collected for histology were routinely stained
with hematoxylin and eosin. Additional histochemical (e.g., Masson trichrome) and/or
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immunohistochemical stains and in situ hybridization techniques (e.g., Epstein–Barr
virus-encoded small RNAs) were used, whenever needed, to reach a diagnosis. The micro-
biological methods have been reported in detail elsewhere [13]. In all patients, screening
for context-epidemiologically common pathogens was conducted, including Plasmodium
falciparum by real-time PCR detection of antibodies against human immunodeficiency
virus (HIV)-1/2, hepatitis B virus surface antigen, and antibodies against hepatitis C
virus. In all HIV-infected patients, the viral load was determined routinely. Additionally,
Toxoplasma gondii, Mycobacterium tuberculosis, and Cryptococcus spp. in CSF and CNS
samples and Pneumocystis jirovecii, Cryptococcus spp., and M. tuberculosis in the lungs
were tested by real-time PCR. Any other microorganisms were only investigated depend-
ing on the pathological findings observed in the MIA-obtained tissues.
After a washout period of 3–6 months, the same team of experts analyzed the samples of the
CDA following the same approach used for the analysis of the MIA samples.
Determination of the cause of death
The methodology for cause of death determination has been detailed elsewhere [5]. Briefly,
once all the analysis of the MIA samples had been completed, a panel composed of a patholo-
gist, a microbiologist, an obstetrician, and an epidemiologist evaluated all the data of the MIA
and assigned the MIA diagnosis, i.e., the disease or condition putatively leading to death. The
participants in the MIA cause of death attribution panel were aware of the external macro-
scopic examination of the body (but not of the organs) and the histological and microbiolog-
ical results obtained in the MIA sampling but were blind for the information on the clinical
records, except for the pregnancy status and gestational age.
After a washout period (minimum time 3 months, range 3–6 months), the same panel eval-
uated the data from the CDA and assigned the CDA diagnosis of cause of death, which was
considered the gold standard. As per routine practice in CDA procedures, investigators
involved in the CDA diagnosis were aware of the clinical data, the macroscopic (external and
internal) findings, and the histological and microbiological results. Using a combination of the
strength of the evidence of the histological and the microbiological findings, a category was
assigned to the certainty of the cause of death attribution of the MIA diagnosis and the CDA
diagnosis (details published elsewhere) [5]. In this particular group, the obstetric history of
severe intrapartum hemorrhage increased by 2 levels the strength of the pathological findings
of the CDA.
All morbid conditions were codified following the International Classification of Diseases,
10th revision for maternal mortality (ICD-10 MM) [10,14]. Up to 4 diagnoses were established
following the most probable sequence of events leading to death, starting from the immediate
cause and going back to the earliest event, i.e., the underlying condition. Finally, other condi-
tions or concomitant infections that may have existed prior to development of the underlying
cause of death or developed during the chain of events leading to death and that, by their
nature, contributed to the death, were considered as contributory conditions (e.g., multiple
pregnancy) [10]. As indicated by WHO, all deaths were classified either as (1) direct obstetric
deaths (i.e., those resulting from obstetric complications of the pregnancy, labor, or puerpe-
rium) or (2) indirect obstetric deaths (i.e., those resulting from previous existing diseases or
diseases developed during pregnancy but not due to direct obstetric causes) [10].
Additionally, all deaths were aggregated in 8 categories according to the underlying causes
of death as stated in the ICD-10 MM [10], which included the following: (1) pregnancies with
abortive outcome; (2) hypertensive disorders in pregnancy, childbirth, and puerperium; (3)
obstetric hemorrhage; (4) pregnancy-related infections; (5) other obstetric complications; (6)
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unanticipated complications of management; (7) nonobstetric complications; and (8) unex-
plained deaths. Nonobstetric complications include the following diseases: cardiovascular
(including preexisting hypertension), endocrine, gastrointestinal tract, CNS, respiratory, geni-
tourinary, autoimmune, skeletal, psychiatric diseases, neoplasm, and infections that are not a
direct result of pregnancy. Categories 1 to 6 were considered direct obstetric deaths, and deaths
classified as category 7 were considered indirect obstetric deaths.
Statistical methods
The concordance between the MIA and the CDA diagnosis (gold standard) was established
based on the concordance in the underlying cause of death categories, was assessed by the
kappa statistic, and was interpreted as suggested by Landis and Koch [15]. The diagnostic per-
formance of the MIA to identify the categories established by the gold standard diagnosis was
evaluated in terms of sensitivity, specificity, positive and negative predictive values, and total
percentage of cases correctly classified.
The level of coincidence between the MIA and the CDA diagnoses was analyzed by com-
paring the ICD-10 MM codes in order to identify the conditions that were concordant in the
disease category but were not coincident in the main diagnosis (e.g., a case categorized as an
indirect obstetric death in both methods but as pneumonia in the CDA and as sepsis in the
MIA). As the ICD-10 system classifies diagnoses into nested classes of different hierarchical
levels in which diseases or conditions are organized in chapters, blocks, and 3-character cate-
gories [14], a coincidence was classified as (i) perfect when the ICD-10 codes were identical in
chapter, block, and 3-character categories; (ii) moderate when the codes were within the same
chapter and block but there was a discrepancy in the 3-character category; or (iii) low when
the codes were within the same chapter but not in the same block and 3-character categories.
When the MIA and the CDA diagnoses were in different chapters, the coincidence was classi-
fied as “none.” The statistical analyses were performed using Stata version 14.1 (Stata, College
Station, TX, USA). The analytical plan was determined once all the histological and microbio-
logical results as well as the ICD10-MM codes were available.
Results
Coupled MIA and CDA procedures were performed in 57 women. Median age was 27 years
(range 15–39 years). Thirty-one women (54%) died in the puerperal period, 9 (16%) died after
an abortion, and 16 (28%) were pregnant at the time of death. In all 16 cases, the fetus and the
placenta were in situ. Nevertheless, no autopsy was performed on these in situ fetuses because
it was not considered as relevant to determine the cause of death. The placenta was analyzed as
part of the CDA in 8 of these cases but was not contributory to the final diagnosis. Forty-four
lived in the Maputo urban area, whereas 13 were transferred from a rural district.
In 40 cases (70%), the interval between death and the beginning of postmortem procedures
was24 hours, whereas in 17/57 (30%), it ranged between 25 and 64 hours. The age of the
patients, time from death to procedure, HIV status, MIA and CDA diagnoses, ICD-10 coding,
level of certainty, and concordance between both diagnoses are shown for all patients in S1
Table.
Blood was obtained in all cases, but in 3 women, less than 10 mL were obtained (in 1 of
these cases, the MIA was done 34 hours after death). In 56/57 cases (98%), 10 mL of CSF were
obtained. In the MIA procedure, liver, CNS, and bone marrow samples were obtained in 100%
of the cases, whereas lung was sampled in 93%, heart in 86%, spleen in 79%, and kidneys in
61% of the cases. The uterus was successfully obtained in 53/57 (93%) of the cases. Amniotic
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fluid was obtained in 7 (12%) cases. The placenta was available for analysis in 8/16 (50%)
women that were pregnant at the time of death.
S1 Table summarizes the cause of death for each patient according to each of the 2 methods
used.
Gold standard (CDA) diagnosis of cause of death
A cause of death was identified in the CDA in 98% (56/57) of cases. The level of certainty of
the CDA diagnosis was considered high or very high in 51/57 (89%) cases and moderate in 5
cases (9%).
Direct obstetric conditions accounted for 24 out of 57 deaths (42%). This included obstetric
hemorrhages (13/24; 54%), complications of abortive pregnancies (6/24; 25%), pregnancy-
related infections (4/24; 17%), and hypertensive disorders of the pregnancy (1/24; 4%)
(Table 1, S1 Table). No deaths were classified in the categories “other obstetric complications”
and “unanticipated complications of management”.
Indirect obstetric conditions accounted for 32/57 (56%) deaths. Among them, infectious
diseases accounted for 22/32 deaths (69%), other diseases not related to pregnancy for 7/32
(22%), and malignant tumors for 3/32 (9%) of the deaths (Table 1, S1 Table). Five women died
of tuberculosis (M. tuberculosis) and 4 of cryptococcal infection. Cerebral malaria with histo-
logical evidence of sequestration of parasitized erythrocytes in the capillaries of the CNS and P.
falciparum detected by PCR was diagnosed in 4 women. Of these 4 patients, 3 (out of 44; 6.8%)
came from the Maputo urban area, whereas 1 (out of 13; 7.7%) was transferred from a rural
district.
HIV was detected in 36 women (63%). All HIV positive cases showed detectable viral load
for HIV-1. HIV infection was identified in 13/24 (54%) women who died from direct obstetric
causes and in 22/32 (69%) women who died from nonobstetric complications. HIV was also
Table 1. Concordance of the cause of death categorization between the MIA and the CDA (gold standard).
MIA diagnosis CDA diagnosis
Pregnancies with
abortive outcome
Hypertensive
disorders in
pregnancy
Obstetric
hemorrhage
Pregnancy-
related infections
Nonobstetric
complications
Non-
conclusive
Total
Pregnancies
with abortive
outcome
5 0 0 0 1 0 6 (11%)
Hypertensive
disorders in
pregnancy
0 1 0 0 0 0 1 (2%)
Obstetric
hemorrhage
0 0 1 0 0 0 1 (2%)
Pregnancy-
related
infections
0 0 1 2 0 0 3 (5%)
Nonobstetric
complications
0 0 6 2 29 0 37
(65%)
Non-
conclusive
1 0 5 0 2 1 9 (16%)
Total 6 (11%) 1 (2%) 13 (23%) 4 (7%) 32 (56%) 1 (2%) 57
(100%)
Kappa statistic: 0.48 (moderate agreement); 95% CI: 0.31–0.66.
Abbreviations: CDA, complete diagnostic autopsy; MIA, minimally invasive autopsy.
https://doi.org/10.1371/journal.pmed.1002431.t001
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detected in the single case with nonconclusive diagnosis. Nearly 3 quarters (16/22; 73%) of the
HIV-positive nonobstetric maternal deaths were considered to be AIDS related, which
included all 5 tuberculosis cases, the 4 cryptococcal disseminated infections, 3 pneumonias, 1
streptococcal sepsis, 1 pyelonephritis, 1 meningoencephalitis, and 1 Burkitt lymphoma. The
other 6 HIV-positive cases died from cerebral malaria (3 cases), liver failure due to massive
liver necrosis (2 cases), and dilated cardiomyopathy (1 case). Hepatitis B virus infection was
identified in 3 HIV-positive cases.
MIA diagnosis and concordance in the categorization of disease
between the MIA and the CDA gold standard diagnosis
A cause of death was identified in the MIA in 48 out of the 57 cases (84%). In 9 cases (16%),
the MIA diagnosis was nonconclusive. The certainty of the MIA diagnosis was high or very
high in 22/48 (46%) cases, moderate in 19/48 (40%), and low in 7/48 (14%).
Table 1 shows the diagnostic concordance between the MIA and the CDA (gold standard)
for the categories of causes of death. The 2 procedures agreed in the diagnostic categories in
39/57 cases (68%) and the concordance was moderate according to the kappa statistics
(kappa = 0.48, 95% CI: 0.31–0.66).
A perfect or almost perfect coincidence in the cause of death established by each method
was observed in 36 of the 39 cases that were concordant in the diagnostic category. One case
showed a low level of coincidence (diagnosed as chronic hypertensive disease in pregnancy in
the CDA and as suggestive of cardiovascular disease in the MIA). The 2 remaining cases were
noncoincident (a case of pneumonia and a case of liver necrosis according to the CDA, diag-
nosed as sepsis due to Escherichia coli and pneumonia, respectively, in the MIA).
Table 2 shows the sensitivity, specificity, and the positive and negative predictive values of
the MIA diagnosis for the major diagnostic categories, as well as the percentage of false-posi-
tive and false-negative diagnoses, and the cases correctly classified (accuracy) in the MIA. The
sensitivity of the MIA was very high for indirect causes of death (91%) and low (<10%) for
obstetric hemorrhage. Overall, the accuracy of the MIA was at least 79% for all diagnostic
categories.
Etiological agents in infectious diseases causes of death
Overall, infectious diseases accounted for 30/57 (57%) of maternal deaths. Infectious diseases
included 8 obstetric infections (4 puerperal sepsis and 4 septic abortions) and 22 nonobstetric
infections. An etiologic agent was identified in the CDA in 22 out of the 30 (73%) infectious
Table 2. Sensitivity, specificity, positive and negative predictive value, and accuracy of the MIA for the different diagnostic categories in maternal
deaths. Figures are percentages and 95% CI. S1 Table summarizes the cause of death for each patient according to each of the 2 methods used.
Causes of death in the CDA
(gold standard)
Cases Sensitivity (95%
CI)
Specificity (95%
CI)
Positive predictive
value (95%CI)
Negative predictive
value (95% CI)
Correctly classified
(95% CI)
Pregnancies with abortive
outcome
6 83 (36–100) 98 (90–100) 83 (36–100) 98 (90–100) 96 (88–100)
Hypertensive disorders 1 100 (2–100) 100 (94–100) 100 (2–100) 96 (94–100) 100 (94–100)
Obstetric hemorrhage 13 8 (0–36) 100 (92–100) 100 (2–100) 79 (66–88) 79 (66–88)
Pregnancy-related infections 4 50 (7–93) 98 (90–100) 67 (9–99) 96 (87–100) 95 (85–99)
Nonobstetric complications 32 91 (75–98) 68 (46–85) 78 (62–90) 85 (62–97) 81 (68–90)
Nonconclusive 1 100 (2–100) 86 (74–94) 11 (0–48) 100 (93–100) 86 (74–94)
Abbreviations: CDA, complete diagnostic autopsy; MIA, minimally invasive autopsy.
https://doi.org/10.1371/journal.pmed.1002431.t002
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diseases (6 obstetric and 16 nonobstetric). The same microorganism was identified in both the
CDA and the MIA in 20 out of the 22 cases (91%). A microorganism was identified in the MIA
in 13 additional cases and considered the MIA cause of death. In 5 cases, both the CDA and
the MIA diagnosed an infectious disease, but whereas the CDA did not identify any microor-
ganism, the MIA identified a causative agent. In 6 cases, the CDA (gold standard) cause of
death was hemorrhagic shock and, consequently, the microorganism identified in the MIA
was considered as not contributing to the death. Finally, in 2 cases, the CDA diagnosed an
infectious disease, probably of bacterial origin, with no agent identifiable (a meningoencepha-
litis and a puerperal sepsis, respectively), whereas in the MIA the cause of death was consid-
ered to be a disseminated cytomegalovirus infection. In both cases, the cytomegalovirus was
also identified in the CDA but it was not considered as the cause of death. Table 3 shows the
etiological agents identified in the CDA and in the MIA.
Table 3. Etiological microorganisms identified in the CDA (gold standard) and in the MIA, and the number identified in both methods.
Etiological microorganisms Microorganisms identified in the
CDA (gold standard)
Microorganisms identified in the
MIA and in the CDA
Microorganisms identified in the MIA
but not in the CDA
Direct obstetric infections
Septic abortion
Enterobacteriaceae* 2 2 -
Escherichia coli 1 1 -
Mycoplasma hominis 1 1 -
Aeromonas sobria† 0 0 1
Staphylococcus aureus 0 0 1
Puerperal sepsis
S. pyogenes 1 1 -
Prevotella spp. 1 0 -
Aeromonas spp.† 0 0 1
Nonobstetric infections
Disseminated infection
Mycobacterium tuberculosis 4 4 -
Cryptococcus spp. 3 3 -
S. pneumoniae 1 1 -
Klebsiella pneumoniae 1 1 2
Cytomegalovirus† 0 0 3
Enterobacteriaceae*,†† 0 0 3
E. coli 0 0 1
Toxoplasma gondii 0 0 1
Pulmonary infection
S. aureus 1 1 -
M. tuberculosis 1 0 -
Central nervous system
infection
Plasmodium falciparum 4 4 -
Cryptococcus spp. 1 1 -
Total 22 20 13
* Mixed infection of at least 2 of these enterobacteria: Enterobacter cloacae, E. coli, or K. pneumoniae
† All the microorganisms identified in the MIA were also identified in the CDA but by definition were not considered as the cause of death.
†† One of the enterobacteria identified in the MIA was also identified in the CDA but was not considered the cause of death.
Abbreviations: CDA, complete diagnostic autopsy; MIA, minimally invasive autopsy.
https://doi.org/10.1371/journal.pmed.1002431.t003
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Discussion
This validation study shows, for the first time to our knowledge, that the MIA, a simplified
postmortem procedure, can provide an acceptable correlation with the gold standard CDA
diagnosis in maternal deaths. In this group, the agreement of the technique was 68% (kappa
statistic: 0.48, 95% CI 0.31–0.66), a percentage of agreement similar to those observed in other
age groups [16,17]. These findings suggest that this new method could provide reliable and rel-
evant data regarding the causes of mortality associated with pregnancy and childbirth, particu-
larly for indirect obstetric deaths, and thus contribute to reducing maternal mortality in the
settings where this burden is highest.
This study was not designed to describe the causes of maternal death. However, our find-
ings are similar to previous reports indicating that obstetric hemorrhage and indirect obstetric
conditions are the leading causes of maternal mortality in low-income countries [18,19]. Inter-
estingly, and unlike what it is usually reported [20,21], the proportion of indirect obstetric
deaths (56%) observed in our study is larger than that of direct obstetric deaths (42%). These
results are similar to a previous study carried out over 10 years ago in the same setting [19]
and suggest that nonobstetric complications may be missed using the current methodologies
and sources of data collection utilized for maternal cause of death estimation. Our study also
confirmed the significant contribution of malaria and HIV to maternal mortality in endemic
countries such as Mozambique [1,19,22,23]. In this series, malaria accounted for 7% (4/57)
and HIV-related conditions for 28% (16/57) of all maternal deaths. Cerebral malaria could be
detected in the MIA in all 4 cases [24], a finding of particular relevance, taking into account
that the study was conducted in an urban setting where malaria transmission is known to be
minimal. Interestingly, 3 out of the 4 women with cerebral malaria were of urban origin,
although we cannot exclude a visit to a rural area with higher malaria transmission during
pregnancy. This finding is very relevant for improving the knowledge on the impact of malaria
on maternal mortality in endemic areas, which is usually underestimated [25]. As observed in
previous reports [19,26,27], HIV and tuberculosis coinfection were found to be important
causes of indirect obstetric deaths (9% of deaths). Tuberculosis was identified in the MIA in 4
out of 5 cases in which the infection was determined to be the cause of death in the CDA. This
is of relevance given the low sensitivity of the clinical diagnosis of tuberculosis as a cause of
maternal mortality [28]. Importantly, disseminated cryptococcal infection contributed signifi-
cantly to death among HIV-positive women (7%, 4/57), and all the cases were also identified
in the MIA. Cryptococcus spp. is the leading cause of adult meningitis in sub-Saharan Africa,
where it is estimated to cause 15%–20% of all AIDS-related deaths [28–30]. Nevertheless, data
in pregnant women are scarce, with only a few published studies having reported cryptococcal
infection among pregnant women. This study highlights the importance of cryptococcosis as a
cause of maternal death and thus the need to improve the diagnosis and management of this
fungal infection during pregnancy [31–33].
Interestingly, the sensitivity of the MIA procedure was very high (91%) for indirect causes
of death. In contrast, the sensitivity was much lower (36%) for direct obstetric causes. The sen-
sitivity of the MIA procedure was particularly poor (less than 10%) for obstetric hemorrhage.
Only 1 case was captured in the MIA because a retained placenta was identified in a woman
during puerperium. Although only 1 death was attributed to eclampsia, the disease was identi-
fied in the MIA. This accuracy was probably influenced by our strict criteria to diagnose
eclampsia, which required the presence of the typical pathological lesions in the liver and the
absence of any other lethal lesion, in order to avoid overassignment of this condition as a cause
of death [28]. This is relevant given the high number of false-positive clinical diagnoses of
eclampsia that has been reported and the likely overestimation of this condition in clinical
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reports and verbal autopsies [34,35]. Indeed, it is essential to establish thoroughly the contribu-
tion of eclampsia to maternal mortality to guide maternal health programs that are based on
preeclampsia prevention.
This study was designed to determine the validity of the MIA procedure by itself, without
using any additional clinical data. The only exception to this purist approach was the knowledge
of whether the death of the woman occurred while pregnant or within 42 days of termination of
pregnancy (irrespective of the duration and the site of the pregnancy), as this information was
essential to know when a case fulfilled the definition of WHO and, consequently, had to be
included as a maternal death. Our findings indicate that the MIA without any clinical data has a
relatively limited performance for direct obstetric causes of death. Some degree of obstetric
information from the clinical record or the verbal autopsy could significantly improve the
results of the MIA. Importantly, obstetric hemorrhage was missed in all but 1 case in the MIA;
however, this condition is easily identified in the clinical records and is likely not to be difficult
to retrieve from a verbal autopsy. On the contrary, most indirect obstetric deaths that are fre-
quently misclassified in verbal autopsies were identified in the MIA. Future research should
focus on the performance of the MIA with the inclusion of clinical data.
The extensive microbiological sampling and analysis proposed in our MIA protocol result
in the adequate identification of the etiological agent in a high number of infectious diseases.
Moreover, in 5 cases considered as infectious by the gold standard, the etiological agent was
successfully identified in the MIA but not in the CDA. It is possible that the less invasive sam-
pling procedure performed in the MIA might improve the performance of the microbiological
analysis by reducing the probability of microbiological contamination [36,37]. On the other
hand, the MIA may result, in the absence of any clinical information, in an overestimation of
the microbiological results, as it may be the cases of the 5 women who died of obstetric hemor-
rhage that were considered as infectious deaths in the MIA.
A limitation of this study is the relatively low sample size, which has resulted in a poor
representation of some causes of death. Nevertheless, the study was not designed to describe
all the causes of maternal death and validate the method for each specific cause or category of
disease but rather to assess the validity of the method for the group of maternal death as a
whole. A second limitation of this study is that its diagnostic accuracy of the MIA could have
been influenced by the dissemination of many diseases. More than half of the patients were
HIV-infected adults with highly disseminated infections, and the performance of the proce-
dure could be significantly reduced in focal lesions and in limited infections in immunocom-
petent hosts. Finally, both the MIA and the CDA include some degree of subjective
interpretation in the attribution of cause of death.
In conclusion, establishing reliably the causes of maternal deaths is crucial for health plan-
ning and prioritization, which in turn are essential elements to reduce maternal mortality. The
lack of quality data on these causes of death in high-burden countries has been recognized as a
major limitation to achieving the 5th Millennium Developmental Goal [38], especially in sub-
Saharan Africa, where the MMR only dropped by 26% since 1990 [1]. In these settings, a tool
such as the MIA might provide quality information mainly for those conditions that are more
difficult to identify through routinely used methods for cause of death determination, while
improving clinical management and verbal autopsies with refined algorithms. This would lead
to improving the most underachieving global health goal, which relates to maternal health.
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